Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SREBF pathway regulator in Golgi 1 (SPRING1) is a protein-coding gene that encodes a regulatory protein primarily localized in the Golgi membrane[5][2]. SPRING1 is involved in the positive regulation of the SREBP (Sterol Regulatory Element Binding Protein) signaling pathway, an essential pathway for lipid homeostasis[8][2]. SPRING1 facilitates this process by modulating the correct localization of SCAP, a key component necessary for SREBP activation, from the endoplasmic reticulum to the Golgi apparatus[8]. While critical for lipid metabolism regulation, SPRING1 is not a direct therapeutic target and is not classified as a receptor, enzyme, transporter, or similar druggable class[8][2]. There is no current evidence for its direct involvement in diseases, interaction with drugs, or use as a clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SREBF pathway regulator in Golgi 1 (SPRING1).